Physician
Guillen, Eduardo
Guillen, Eduardo was paid $201K by Medicaid between Dec 2019 and Dec 2024, across 15 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoGUILLEN, EDUARDO
EDINBURG, TX 78539
EDINBURG, TX 78539
33aNPI1649384140assigned 08/19/2006
33bProvider typePediatrics Physician
28Total paid$201K
24GClaims8,487
24DCodes billed15
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#636 of 1,136
Median peer was paid$329K
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 153 | $2K | |
| 2020 | 934 | $6K | |
| 2021 | 1,729 | $38K | |
| 2022 | 2,080 | $54K | |
| 2023 | 2,138 | $62K | |
| 2024incomplete | 1,453 | $38K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 2,561 | 2,162 | $91K |
| 86328 | 22% | 522 | 479 | $44K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12% | 479 | 450 | $24K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5.0% | 803 | 725 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.9% | 1,616 | 1,451 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.5% | 802 | 393 | $9K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.9% | 217 | 203 | $8K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 24 | 24 | $2K |
| 97802 | <1% | 855 | 428 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 89 | 41 | $687.62 |
| 92551 | <1% | 41 | 41 | $326.04 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 13 | 13 | $129.61 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.